Amber Salzman, Ph.D.
Advertisement
Amber Salzman, Ph.D., is the president and CEO of Ohana Biosciences.
Articles by Amber Salzman, Ph.D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
AAPS PharmSci 360 2025: Trends in Bioanalysis
3
PharmTech Weekly News Roundup – Week of November 3, 2025
4
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
5
